This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After Novartis’ Pluvicto shook up iSpot.TV’s monthly rankings of the top TV adve...
In his third year as the CEO of Johnson & Johnson, Joaquin Duato received an ove...
In his third year as the CEO of Johnson & Johnson, Joaquin Duato received an ove...
In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simul...
The facility will be used to develop and produce Entos' Fusogenix proteolipid ve...
After Gilead’s lenacapavir made waves with stellar clinical results as a twice-y...
After Gilead’s lenacapavir made waves with stellar clinical results as a twice-y...
At its sprawling manufacturing complex in Durham, N.C., Merck has opened a new $...
For his work in 2024, AbbVie helmsman Robert Michael—who took over the CEO post ...
Tenpoint Therapeutics has tasked Carol Kearney with cracking a market that confo...
The deal, which is expected to close in mid-2025, marks the divesture of Endo's ...
Obesity upstart Viking Therapeutics has agreed to pay a total of $150 million th...
More than a year into a strategic pivot to zero in on the multiple myeloma cell ...
The opening of the new 100,000-square-foot facility at Almac's headquarters in C...
Indian CRDMO Syngene International is paying $36.5 million to acquire Emergent B...
In exercising some of his stock options in 2024, BioNTech CEO Uğur Şahin, M.D., ...
Roche has recently launched a “fundamental reorganization” of Spark Therapeutics...
Activist investor Starboard Value proposed four additions to Kenvue's board last...
Activist investor Starboard Value proposed four additions to Kenvue's board last...
Incyte's Opzelura was successful in just one of two parallel phase 3 trials asse...
Every year, amid Women’s History Month, March 8 marks International Women’s Day—...
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint...
Presiding over the upward trajectory of Eli Lilly over the last eight years has ...
The FDA last week approved Neurotech’s cell therapy implant revakinagene taroret...